Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2014
10/28/2014US8871226 Methods and compositions for the treatment and diagnosis of cancer
10/23/2014US20140314756 Method for treating psoriasis
10/21/2014US8865768 Use of polyunsaturated ketones for the treatment of psoriasis
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/21/2014US8865690 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents
10/21/2014US8865655 Depsipeptides and their therapeutic use
10/21/2014US8865643 Recombinant surfactant protein D compositions and methods of use thereof
10/21/2014US8865235 Microbicidal and antiparasitic compositions
10/21/2014US8865177 Pressure sore treatment
10/21/2014US8865143 Reversely thermo-reversible hydrogel compositions
10/21/2014US8865138 Melanin modification compositions and methods of use
10/16/2014US20140308376 Cosmetic Compositions and Methods for Using Same to Improve the Aesthetic Appearance of Skin
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/16/2014US20140308223 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
10/14/2014US8859747 Promoters exhibiting endothelial cell specificity and methods of using same
10/14/2014US8859745 Promoters exhibiting endothelial cell specificity and methods of using same
10/09/2014WO2014165136A1 Constant volume prefilled syringes and kits thereof
10/09/2014WO2014164886A1 Prostanoid receptor agonist compounds and their use
10/09/2014WO2014164617A1 Cosmetic use of napthoic acid derivatives
10/09/2014WO2014163298A1 Extraction method for separating noni residue extract exhibiting strong skin protection effect and composition containing same for protecting skin and for treating and preventing skin aging
10/09/2014WO2014163219A1 Novel phytospingosine-1-phosphate derivative, preparation method therefor, and composition for preventing and treating hair loss or for growing hair comprising same
10/09/2014WO2014163178A1 Elastin synthesis/regeneration promoting agent
10/09/2014WO2014161891A1 Ingenol mebutate in combination with laser therapy for the treatment of hyperkeratotic skin lesions
10/09/2014WO2014161085A1 Schiff-based aldehydic hyaluronic acid-chitosan hydrogel compositions and uses thereof
10/09/2014US20140303215 Topically applicable pharmaceutical preparation
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140301998 Preparation containing diol
10/08/2014EP2786996A1 Purinone derivative hydrochloride
10/08/2014EP2786986A2 Novel benzamide derivative and use thereof
10/08/2014EP2786747A1 Promoting hair growth solution containing chlorine dioxide preparation method and use method thereof
10/08/2014EP2786741A1 Whitening cosmetic
10/08/2014EP2785356A1 Use of pullulan for alleviating the appearance of scars or scar tissue
10/08/2014EP2785336A1 Use of pegylated alcohols for the treatment of actinic keratosis
10/08/2014EP2785335A1 Methods and pharmaceutical compositions for the treatment of darier disease
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853361 Preparation, for use, in particular, for tissue augmentation and healing
10/07/2014US8853271 Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using tormentic acid
10/07/2014US8853267 N-alkylcarbonyl-amino acid ester compounds and their use for skin irritation, itch, and pain
10/07/2014US8853264 Use of lignan compounds for treating or preventing inflammatory disease
10/07/2014US8853216 Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
10/02/2014WO2014160521A1 Piperazine derivatives and their use as kit modulators
10/02/2014WO2014160279A1 Stabilized cream formulations comprising sandalwood oil
10/02/2014WO2014159987A1 Hair treatment systems and methods using peptides and other compositions
10/02/2014WO2014159771A1 Prevention of rosacea inflammation
10/02/2014WO2014159662A1 Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
10/02/2014WO2014159637A1 Methods of treating b2-bradykinin receptor mediated angioedema
10/02/2014WO2014159419A1 Hydrocolloid wound dressings with increased wvtr
10/02/2014WO2014159238A1 Cosmetic compositions
10/02/2014WO2014158671A1 Abutilon indicum extracts and methods of use
10/02/2014WO2014158373A1 Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith
10/02/2014WO2014157910A1 Composition containing enzyme-treated thanaka extract
10/02/2014WO2014157752A1 Method for manufacturing emulsion bead by low-temperature cooling, and emulsion bead yielded thereby
10/02/2014WO2014157569A1 Heterocyclic compound
10/02/2014WO2014157540A1 Anti-inflammatory agent
10/02/2014WO2014157485A1 Peptide with anti-aging effect and use thereof
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014157380A1 Therapeutic agent for wounds or fibrosis
10/02/2014WO2014157174A1 Composition for body, and anti-fungal agent against malassezia
10/02/2014WO2014157158A1 Phenyl derivative
10/02/2014WO2014155301A1 Substituted bicyclic compounds as inhibitors of ezh2
10/02/2014WO2014155111A1 Skincare compositions
10/02/2014WO2014154026A1 PI3K AND/OR mTOR INHIBITOR PRODRUG
10/02/2014WO2014153666A1 Indoline compounds as granzyme b inhibitors
10/02/2014US20140296345 Method of enhancing hair growth
10/02/2014US20140294881 Proteases producing an altered immunological response and methods of making and using the same
10/02/2014US20140294857 Methods of obtaining a specific binding member that binds eotaxin
10/02/2014US20140294842 Assays, Methods and Means
10/02/2014US20140294829 Anti-ngf antibodies for the treatment of various disorders
10/01/2014EP2783690A1 New use of neohesperidin
10/01/2014EP2782902A2 Derivatives of phenoxyisobutyric acid
10/01/2014EP2782643A1 Androgen receptor ligands
10/01/2014EP2782573A1 1,4- dihydropyridine derivatives with hsp modulating activity
10/01/2014EP2782567A1 Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa)
09/2014
09/30/2014US8846696 Purine derivatives
09/30/2014US8846688 Sodium channel blockers
09/30/2014US8846605 Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
09/30/2014US8846401 Promoters exhibiting endothelial cell specificity and methods of using same
09/30/2014US8846118 Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
09/30/2014US8846092 Gum resin as a carrier for topical application of pharmacologically active agents
09/26/2014CA2810988A1 Topical gels for use in contact sports
09/25/2014WO2014153164A1 Targeting agent antibody conjugates and uses thereof
09/25/2014WO2014152663A1 Crystalline forms of tyrosine kinase inhibitors and their salts
09/25/2014WO2014152621A1 P2x7 modulators
09/25/2014WO2014152511A1 Methods for promoting wound healing and hair growth
09/25/2014WO2014151107A1 Wound healing compositions
09/25/2014WO2014150782A1 Ketal adducts, methods of manufacture, and uses thereof
09/25/2014WO2014150596A1 Compositions for treating skin disorders
09/25/2014WO2014150074A1 Compositions and methods for nucleic acid delivery
09/25/2014WO2014149674A1 Controlled release pharmaceutical dosage forms
09/25/2014WO2014148574A1 Inhibition of production of il-2
09/25/2014WO2014147622A1 Compositions comprising collagen and prp for tissue regeneration
09/25/2014WO2014147526A1 Tofacitinib oral sustained release dosage forms
09/25/2014WO2014146249A1 Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/25/2014US20140287028 Use of Chemotherapeutic Agents
09/25/2014US20140287020 Surgical device for skin therapy or testing
09/25/2014US20140286949 Method of attenuating reactions to skin irritants
09/25/2014DE102013204110A1 Wirkstoffkombinationen aus Alkylamidothiazolen und einem oder mehreren Cyclodextrinen Active ingredient combinations of one or more cyclodextrins and Alkylamidothiazolen
09/24/2014EP2781520A1 Three-ring pi3k and/or mtor inhibitor
09/24/2014EP2781216A1 Chemokine receptor activity regulator
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 1065